Search Results - "Ma, Ida"

Exposure–Response Analyses of Olaparib in Real-Life Patients with Ovarian Cancer by Mohmaed Ali, Ma Ida, Bruin, Maaike A. C., Dezentjé, Vincent O., Beijnen, Jos H., Steeghs, Neeltje, Huitema, Alwin D. R.

“…Background Olaparib is given in a fixed dose of twice-daily 300 mg in patients who are diagnosed with ovarian cancer, breast cancer, prostate cancer or…”
Get full text

Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data by Lau, Cedric, Mohmaed Ali, Ma Ida, Lin, Lishi, van Balen, Dorieke E. M., Jacobs, Bart A. W., Nuijen, Bastiaan, Smeenk, Robert M., Steeghs, Neeltje, Huitema, Alwin D. R.

“…Purpose The number of patients with bariatric surgery who receive oral anticancer drugs is rising. Bariatric surgery may affect the absorption of oral…”
Get full text

Pharmacokinetic boosting of olaparib: A randomised, cross-over study (PROACTIVE-study) by Overbeek, Joanneke K., Guchelaar, Niels A.D., Mohmaed Ali, Ma Ida, Ottevanger, Petronella B., Bloemendal, Haiko J., Koolen, Stijn L.W., Mathijssen, Ron H.J., Boere, Ingrid A., Hamberg, Paul, Huitema, Alwin D.R., Sonke, Gabe S., Opdam, Frans L., ter Heine, Rob, van Erp, Nielka P.

“…Pharmacokinetic (PK) boosting is the intentional use of a drug-drug interaction to enhance systemic drug exposure. PK boosting of olaparib, a CYP3A-substrate,…”
Get full text

Research priority-setting for human, plant, and animal virology: an online experience for the Virology Institute of the Philippines by Sales, Reneepearl Kim, Oraño, Joseph, Estanislao, Rafael Deo, Ballesteros, Alfredo Jose, Gomez, Ma Ida Faye

“…Viral pandemics have had catastrophic consequences on population health and economies. The Philippine government intends to establish the Virology Institute of…”
Get full text

Assessment of the Biosafety and Biosecurity Landscape in the Philippines and the Development of the National Biorisk Management Framework by Destura, Raul V, Lam, Hilton Y, Navarro, Rohani C, Lopez, Jaifred Christian F, Sales, Reneepearl Kim P, Gomez, Ma Ida Faye A, Dela Tonga, Angelo, Ulanday, Gianne Eduard

“…The emergence of biological threats that can potentially affect millions emphasizes the need to develop a policy framework in the Philippines that can mount an…”
Get full text

Discovery of Tetrahydropyrazolopyrimidine Carboxamide Derivatives As Potent and Orally Active Antitubercular Agents by Yokokawa, Fumiaki, Wang, Gang, Chan, Wai Ling, Ang, Shi Hua, Wong, Josephine, Ma, Ida, Rao, Srinivasa P S, Manjunatha, Ujjini, Lakshminarayana, Suresh B, Herve, Maxime, Kounde, Cyrille, Tan, Bee Huat, Thayalan, Pamela, Ng, Seow Hwee, Nanjundappa, Mahesh, Ravindran, Sindhu, Gee, Peck, Tan, Maria, Wei, Liu, Goh, Anne, Chen, Pei-Yu, Lee, Kok Sin, Zhong, Chen, Wagner, Trixie, Dix, Ina, Chatterjee, Arnab K, Pethe, Kevin, Kuhen, Kelli, Glynne, Richard, Smith, Paul, Bifani, Pablo, Jiricek, Jan

“…Tetrahydropyrazolo[1,5-a]pyrimidine scaffold was identified as a hit series from a Mycobacterium tuberculosis (Mtb) whole cell high through-put screening (HTS)…”
Get full text

A Population Pharmacokinetic Study to Evaluate Doxorubicin Exposure Across All Age Groups by Mohmaed Ali, Ma Ida, Nijstad, A. Laura, Boosman, René J., Crombag, Marie-Rose B. S., Barnett, Shelby, Veal, Gareth J., Lalmohamed, Arief, van Erp, Nielka P., Steeghs, Neeltje, Zwaan, C. Michel, Beijnen, Jos H., Siebinga, Hinke, Huitema, Alwin D. R.

“…The effect of age on doxorubicin pharmacokinetics remains inconclusive, especially in patients at the extremes of the age spectrum. We developed a population…”
Get full text

Cortisol as Biomarker for CYP17-Inhibition is Associated with Therapy Outcome of Abiraterone Acetate by Bruin, Maaike A. C., Mohmaed Ali, Ma Ida, van Nuland, Merel, Jacobs, Bart A. W., Lucas, Luc, Dezentje, Vincent O., de Feijter, Jeantine M., Rosing, Hilde, Bergman, Andries M., Beijnen, Jos H., Huitema, Alwin D. R.

“…Background Abiraterone acetate is an irreversible 17α-hydroxylase/C17, 20-lyase (CYP17) inhibitor approved for the treatment of metastatic castration-resistant…”
Get full text

A chemical genetic screen in Mycobacterium tuberculosis identifies carbon-source-dependent growth inhibitors devoid of in vivo efficacy by Pethe, Kevin, Sequeira, Patricia C, Agarwalla, Sanjay, Rhee, Kyu, Kuhen, Kelli, Phong, Wai Yee, Patel, Viral, Beer, David, Walker, John R, Duraiswamy, Jeyaraj, Jiricek, Jan, Keller, Thomas H, Chatterjee, Arnab, Tan, Mai Ping, Ujjini, Manjunatha, Rao, Srinivasa P.S, Camacho, Luis, Bifani, Pablo, Mak, Puiying A, Ma, Ida, Barnes, S. Whitney, Chen, Zhong, Plouffe, David, Thayalan, Pamela, Ng, Seow Hwee, Au, Melvin, Lee, Boon Heng, Tan, Bee Huat, Ravindran, Sindhu, Nanjundappa, Mahesh, Lin, Xiuhua, Goh, Anne, Lakshminarayana, Suresh B, Shoen, Carolyn, Cynamon, Michael, Kreiswirth, Barry, Dartois, Veronique, Peters, Eric C, Glynne, Richard, Brenner, Sydney, Dick, Thomas

“…Candidate antibacterials are usually identified on the basis of their in vitro activity. However, the apparent inhibitory activity of new leads can be…”
Get full text

External validity of an automated delirium prediction model (DEMO) and comparison to the manual VMS-questions: a retrospective cohort study by Ali, Ma Ida Mohmaed, Kalkman, Gerard A., Wijers, Charlotte H. W., Fleuren, Hanneke W. H. A., Kramers, Cornelis, de Wit, Hugo A. J. M.

“…Background It is estimated that one-third of delirium cases in hospitals could be prevented with appropriate interventions. In Dutch hospitals a manual…”
Get full text

Peptide deformylase inhibitors of Mycobacterium tuberculosis: Synthesis, structural investigations, and biological results by Pichota, Arkadius, Duraiswamy, Jeyaraj, Yin, Zheng, Keller, Thomas H., Alam, Jenefer, Liung, Sarah, Lee, Gladys, Ding, Mei, Wang, Gang, Chan, Wai Ling, Schreiber, Mark, Ma, Ida, Beer, David, Ngew, Xinyi, Mukherjee, Kakoli, Nanjundappa, Mahesh, Teo, Jeanette W.P., Thayalan, Pamela, Yap, Amelia, Dick, Thomas, Meng, Wuyi, Xu, Mei, Koehn, James, Pan, Shi-Hao, Clark, Kirk, Xie, Xiaoling, Shoen, Carolyn, Cynamon, Michael

“…Bacterial peptide deformylase (PDF) belongs to a subfamily of metalloproteases catalyzing the removal of the N-terminal formyl group from newly synthesized…”
Get full text

Corrrection to Discovery of Tetrahydropyrazolopyrimidine Carboxamide Derivatives As Potent and Orally Active Novel Antitubercular Agents by Yokokawa, Fumiaki, Wang, Gang, Chan, Wai Ling, Ang, Shi Hua, Wong, Josephine, Ma, Ida, Rao, Srinivasa P S, Manjunatha, Ujjini, Lakshminarayana, Suresh B, Herve, Maxime, Kounde, Cyrille, Tan, Bee Huat, Thayalan, Pamela, Dick, Thomas, Ng, Seow Hwee, Nanjundappa, Mahesh, Ravindran, Sindhu, Gee, Peck, Tan, Maria, Wei, Liu, Goh, Anne, Chen, Pei-Yu, Lee, Kok Sin, Zhang, Chen, Wagner, Trixie, Dix, Ina, Chatterjee, Arnab, Pethe, Kevin, Kuhen, Kelli, Glynne, Richard, Smith, Paul, Bifani, Pablo, Jiricek, Jan

Get full text

[S4Cd17(SPh)28]2-, the first member of a third series of tetrahedral [SWMX(SR)y]z- clusters by Lee, Garry S. H, Craig, Don C, Ma, Ida, Scudder, Marcia L, Bailey, Trevor D, Dance, Ian G

Get full text

Mercury polysulfide complexes, [Hg(Sx)(Sy)]2-: syntheses, mercury-199 NMR studies in solution, and crystal structure of (Ph4P)4[Hg(S4)2]Br2 by Bailey, Trevor D, Banda, R. M. Herath, Craig, Donald C, Dance, Ian G, Ma, Ida N. L, Scudder, Marcia L

Get full text

Barents-2.5km v2.0: an operational data-assimilative coupled ocean and sea ice ensemble prediction model for the Barents Sea and Svalbard by Röhrs, Johannes, Gusdal, Yvonne, Rikardsen, Edel S. U, Durán Moro, Marina, Brændshøi, Jostein, Kristensen, Nils Melsom, Fritzner, Sindre, Wang, Keguang, Sperrevik, Ann Kristin, Idžanovic, Martina, Lavergne, Thomas, Debernard, Jens Boldingh, Christensen, Kai H

“…An operational ocean and sea ice forecast model, Barents-2.5, is implemented for short-term forecasting at the coast off northern Norway, the Barents Sea, and…”
Get full text